Pharmaceutical Executive-03-25-2009

Pharmaceutical Executive

Lilly's Zyprexa/Prozac Combo Approved for Depression

March 25, 2009

News Analysis

0

0

After repeated requests for additional study information, the wait has paid off: Lilly was approved to sell its bipolar drug Symbyax for treatment-resistant depression.